A recent report showed that epidermal Rora deletion alleviated imiquimod-induced psoriatic-like skin inflammations by attenuating the activation of nuclear factor-κB (NF-κB and STAT3 in keratinocytes) [66]. This evidence concerns the gene NFKB1 and dermatitis.